THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 126 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | -98.9% | 3,700 | -59.0% | 0.00% | -100.0% |
| Q4 2021 | $95,000 | +9400.0% | 9,023 | -24.2% | 0.00% | – |
| Q3 2021 | $1,000 | -97.8% | 11,900 | +83.1% | 0.00% | -100.0% |
| Q1 2021 | $45,000 | +36.4% | 6,500 | +62.5% | 0.00% | +100.0% |
| Q1 2020 | $33,000 | +371.4% | 4,000 | +928.3% | 0.00% | 0.0% |
| Q3 2019 | $7,000 | -98.3% | 389 | -99.0% | 0.00% | -97.4% |
| Q2 2019 | $413,000 | +68.6% | 37,646 | +32.1% | 0.04% | +56.0% |
| Q1 2019 | $245,000 | +24400.0% | 28,500 | +470.0% | 0.02% | – |
| Q2 2018 | $1,000 | -75.0% | 5,000 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 10,898,879 | $264,297,000 | 23.51% |
| Foundation Asset Management, LP | 399,537 | $9,689,000 | 3.59% |
| Cormorant Asset Management, LP | 1,300,000 | $31,525,000 | 2.35% |
| Baupost Group | 9,309,168 | $225,747,000 | 2.18% |
| Old West Investment Management, LLC | 109,320 | $2,651,000 | 1.53% |
| SENZAR ASSET MANAGEMENT, LLC | 187,856 | $4,555,000 | 1.44% |
| Chescapmanager LLC | 350,631 | $8,503,000 | 1.27% |
| Virtus ETF Advisers LLC | 32,989 | $800,000 | 0.69% |
| Rock Springs Capital Management LP | 652,600 | $15,826,000 | 0.68% |
| NJ State Employees Deferred Compensation Plan | 34,142 | $828,000 | 0.15% |